Inpegsomatropin is under clinical development by Xiamen Amoytop Biotech and currently in Phase II for Turner Syndrome.

Human papillomavirus (9-valent) vaccine is under clinical development by Xiamen Innovax Biotech and currently in Phase II for Human Papillomavirus Infections.

Taiwan's Mainland Affairs Council is investigating claims from a video alleging China's political influence on young ...

China’s Mainland Affairs Council (MAC) said they will investigate claims made in a YouTube video about China’s efforts to ...

China is the world's top fish consumer and is spending billions on technology designed to restock the oceans. But will this ...

Chinese conglomerate Xiamen C&D and Russia's Nornickel are in talks to create a joint venture in China to process Nornickel's ...

We are excited to bring The Ritz-Carlton to Xiamen, offering guests the opportunity to indulge in our legendary luxury ...

Penang’s tourism sector is thriving, with China remaining one of its top international visitor sources in 2024.

In July, China unveiled a landmark resolution to set the stage for a new phase of reform aimed at advancing Chinese modernization. With a focus on the next five years, the blueprint outlines over 300 ...

Univest Securities, LLC is acting as the sole placement agent.

International announced the signing of an agreement with Xiamen Green Development Investment Group to introduce The ...

The world’s largest maker of batteries for electric vehicles says it will get into battery swapping in China in a big way ...